Filing Details
- Accession Number:
- 0001209191-18-042414
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-07-12 07:12:15
- Reporting Period:
- 2018-07-11
- Accepted Time:
- 2018-07-12 07:12:15
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
944809 | Opko Health Inc. | OPK | Pharmaceutical Preparations (2834) | 752402409 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1735476 | Scott Robert Fishel | 4400 Biscayne Blvd. Miami FL 33137 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-07-11 | 2,500 | $6.00 | 4,060,728 | No | 4 | P | Indirect | See Footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | See Footnote |
Footnotes
- These securities are held by ALSAR Ltd. Partnership, of which Dr. Fishel is the President and CEO. The general partner of ALSAR Ltd. Partnership is SARAL Corporation. Dr. Fishel is the sole shareholder and the sole and exclusive beneficiary of SARAL Corporation.